Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04890639 · ClinicalTrials.gov registry record · NA
Acute Intermittent Hypoxia in Traumatic Brain Injury
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04890639 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 12 participants.
The verdict
NCT04890639, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study is designed to answer questions related to safety and preliminary efficacy of Acute Intermittent Hypoxia (AIH) in Traumatic Brain Injury (TBI) survivors. First, we aim to establish whether brief reductions in inhaled oxygen concentration can be safely tolerated in TBI survivors. Second, we aim to establish whether there are any effects of AIH on memory, cognition, and motor control. Participants will be monitored closely for any adverse events during these experiments. Data will be analyzed to determine if there is an improvement in key outcomes at any dose level.
Interventions
- PROCEDURE Acute Intermittent Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2024-01-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04890639
The ClinicalTrials.gov registry entry for NCT04890639 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acute Intermittent Hypoxia is the first listed.
NCT04890639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04890639 about?
NCT04890639 is a clinical study titled "Acute Intermittent Hypoxia in Traumatic Brain Injury". This study is designed to answer questions related to safety and preliminary efficacy of Acute Intermittent Hypoxia (AIH) in Traumatic Brain Injury (TBI) survivors. First, we aim to establish whether brief reductions in inhaled oxygen concentration can be safely tolerated in TBI survivors. Second, w...
What is the current status of trial NCT04890639?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-03-15. Estimated completion is 2024-01-29.
What interventions are being tested in trial NCT04890639?
The interventions under investigation include: Acute Intermittent Hypoxia (PROCEDURE).
Who is sponsoring clinical trial NCT04890639?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.